Is this you? Create Your Porfile
Avatar

Hans-Peter Muhn

Schering AG

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Hans-Peter Muhn is active.

Explore More

Publication

Featured researches published by Hans-Peter Muhn.

Archive | 1998

Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity

Manfred Lehmann; Klaus Schöllkopf; Peter Strehlke; Nikolaus Heinrich; Karl-Heinrich Fritzemeier; Hans-Peter Muhn; Rolf Krattenmacher

Archive | 2005

18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same

Rolf Bohlmann; Dieter Bittler; Hermann Kuenzer; Peter Esperling; Hans-Peter Muhn; Karl-Heinrich Fritzemeier; Ulrike Fuhrmann; Katja Prelle; Steffen Borden

Archive | 2006

Acyltryptophanols for fertility control

Lars Wortmann; Arwed Cleve; Hans-Peter Muhn; Gernot Langer; Anna Schrey; Ronald Kühne; Bernd Menzenbach; Marcus Koppitz; Dirk Kosemund

Archive | 2007

18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one) and pharmaceutical preparations containing the same

Rolf Bohlmann; Joachim Kuhnke; Jan Hübner; Norbert Gallus; Frederik Menges; Steffen Borden; Hans-Peter Muhn; Katja Prelle

Archive | 2010

PYRIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF

Jan Hübner; Christof Wegscheid-Gerlach; Olaf Panknin; Sven Ring; Stefan Bäurle; Christoph Huwe; Katrin Nowak; Reinhard Nubbemeyer; Hans-Peter Muhn

Archive | 2003

Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids

Ludwig Zorn; Rolf Bohlmann; Norbert Gallus; Hermann Kuenzer; Hans-Peter Muhn; Reinhard Nubbemeyer

Archive | 2003

Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-halogen steroids that can be produced therefrom, their process for production and use as well as pharmaceutical prepartions that contain these compounds, as well as 7-substituted estra-1,3,5(10)-trienses that can be produced therefrom

Ludwig Zorn; Rolf Bohlmann; Norbert Gallus; Hermann Kuenzer; Hans-Peter Muhn; Reinhard Nubbemeyer

Archive | 1995

14ALPHA,17ALPHA-C2-BRIDGED 19-NOR-PROGESTERONE DERIVATIVES

Karl-Heinrich Fritzemeier; Wolfgang Halfbrodt; Rolf Krattenmacher; Joachim Kuhnke; Hans-Peter Muhn; Klaus Schöllkopf; Wolfgang Schwede

Archive | 2007

New acyltryptophanols useful for fertility control in men or in women, and for preventing or treating osteoporosis

Lars Wortmann; Arwed Clewe; Bernd Menzenbach; Anna Schrey; Ronald Kühne; Hans-Peter Muhn; Gernot Langer

Archive | 2004

8beta-Vinyl-11beta-(omega-substituted)alkyl-estra-1,3,5(10)-trienes

Nico Braeuer; Olaf Peters; Alexander Hillisch; Rolf Bohlmann; Margit Richter; Hans-Peter Muhn

Explore More

Collaboration

Dive into the Hans-Peter Muhn's collaboration.

Top Co-Authors
Avatar

Rolf Bohlmann

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Joachim Kuhnke

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Steffen Borden

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Frederik Menges

Bayer Schering Pharma AG

View shared research outputs
Top Co-Authors
Avatar

Karl-Heinrich Fritzemeier

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Jan Hübner

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Sven Ring

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Thomas Frenzel

Bayer Schering Pharma AG

View shared research outputs
Top Co-Authors
Avatar

Ulrich Klar

Bayer

View shared research outputs
Top Co-Authors
Avatar

Rolf Krattenmacher

Schering AG

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge